ArticleSN comprehensive clinical medicine2020
COVID-19-Induced Psychosis and Suicidal Behavior: Case Report.
Article in SN comprehensive clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 74 citations in OpenAlex.
- Psychosis during the COVID-19 pandemic: A systematic review of case reports and case series.Journal of psychiatric research · 2022Pooled it
- COVID-19-associated psychosis: A systematic review of case reports.General hospital psychiatryPooled it
- The Use of Electroconvulsive Therapy in Neuropsychiatric Complications of Coronavirus Disease 2019: A Systematic Literature Review and Case Report.Journal of the Academy of Consultation-Liaison PsychiatryPooled it
- Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.Medicina (Kaunas, Lithuania) · 2025Observational
- Article
- Clinical Features and Prognosis of Coronavirus Disease 2019-Related Psychosis: A Retrospective Case Series.Alpha psychiatry · 2023Article
- Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin.Biological psychiatry · 2023Article
- COVID-19-induced Acute Psychosis Resulting in a Suicide Attempt: A Case Report.Clinical practice and cases in emergency medicine · 2023Article
- COVID-19 induced psychosis: A case report.Psychiatry research · 2023Article
- The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients.Frontiers in neuroscience · 2023Article
- Recent advances in electroconvulsive therapy in clinical practice and research.Faculty reviews · 2023Review
- The comorbidity of somatic symptom and major depressive disorders in the times of COVID-19 lockdown in adolescence: A case-report study.SAGE open medical case reports · 2023Article
- New-onset psychosis following COVID-19 infection in a patient with no psychiatric history: A longitudinal case report.Psychiatry research case reports · 2022Article
- COVID-19-induced new-onset psychosis: a case report.Psychiatry research case reports · 2022Article
- Depression and Related Factors in Korean Adults During the Coronavirus Disease 2019 Outbreak.Psychiatry investigation · 2022Article
- The association between fear of COVID-19 and depression, anxiety, and psychosis among Lebanese chronic patients with schizophrenia: any moderating effect of spirituality?Croatian medical journal · 2022Article
- Acute psychosis post-COVID-19 pneumonia.Neurology and clinical neuroscience · 2022Article
- First episode psychosis and COVID-19: A case series and mini review.Asian journal of psychiatry · 2022Review
- Hereditary Thrombophilia in the Era of COVID-19.Healthcare (Basel, Switzerland) · 2022Review
- Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?Neuroscience and biobehavioral reviews · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic is associated with different types of stressors: fear of infection, financial burden, and social isolation. Additionally, COVID-19 infection seems to increase the risk for neuropsychiatric symptoms including psychosis. We present a case of a 52-year-old male with no previous psychiatric history who developed severe paranoia leading to a suicide attempt. He was successfully treated with a combination of milieu treatment, pharmacotherapy, and electroconvulsive therapy. We add to the nascent literature that COVID-19, as other coronaviruses, can increase the risk for severe psychosis and suicidal behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.